bpc 157 safety human study bpc-157 clinical trials evidence review regulatory status Umbrella Labs BPC157 Liquid Spray Peptide BPC-157: Experimental Peptide Creates Risk
Description
USADA acts on tips, which is exactly what Canaday filed

At REVAMP, Tirzepatide + B12 is administered under careful clinical supervision with ongoing monitoring to ensure safety and effectiveness
Additionally, most studies have been conducted over short durations, which might not allow time for adverse effects to manifest

Also what defines these as a drug as opposed to a supplement?

Stanley TL, Fourman LT, Feldpausch MN, et al